This independent meeting is sponsored by pharmaceutical companies, who have had no influence over, or input into, the meeting agenda or content or selection of speakers, except in the sponsored symposia sessions. Sponsors will not be contributing in any way to any hospitality associated with the meeting.
Is it for me?
Our meetings are aimed at healthcare professionals and are aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines. Feedback from past delegates has been very positive with 100% of delegates at our last meeting saying the meeting was clinically excellent to good.
Accreditation
The Cardiorenal Forum will award 5 CPD credits for this meeting.
Academic endorsement
Past meetings have been endorsed by The British Society for Heart Failure, The Irish Nephrology Society, KDIGO – Kidney Disease Improving Global Outcomes, The UK Kidney Association, and The UK Renal Pharmacy Group.
Registration fee
Our registration fees are subsidised and we are pleased to be able to keep these the same as last year. Registration fees to include lunch and refreshments throughout the day are: £125 doctors (SpR and consultant grades), £90 concessions (nurses, trainees, allied HCPs), £325 commercial organisations. All fees are inclusive of VAT.
Travel grants
Travel grants will be available for concession rate delegates (i.e. nurses, trainees and other HCPs) living outside the M25 area. Closing date for applications is 24th July 2026. Click here for further information.
Meeting location
The meeting is taking place in central London at The King’s Fund, Deans Mews entrance, 11–13 Cavendish Square, London W1G 0AN. A map can be downloaded below.
| 09:25 | Introduction Chairs: TBC |
| 09.30 | The gut microbiome – implications for cardiorenal health and disease Professor Julie Lovegrove, Director of the Hugh Sinclair Unit of Human Nutrition, University of Reading |
| 09.50 | Medically targeting obesity to reduce polyvascular risk Dr Alexander Miras, Senior Clinical Lecturer and Consultant in Endocrinology, Imperial College, London |
| 10.10 | Discussion |
| Chair: Professor Indranil Dasgupta, Consultant in Renal Medicine and Hypertension, Heartlands Hospital, University Hospitals Birmingham | |
| 10:15 | Research and clinical priorities for diabetic kidney disease and hypertension Dr Pauline Swift, Consultant Nephrologist, Epsom and St Helier University Hospitals NHS Trust |
| 10:35 | Cardiorenal disease – targeting inflammation and fibrosis Professor Claire Hills, Chair of Renal Physiology, University of Lincoln |
| 10:55 | Who should we treat, with what, and when? Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester |
| 11.15 | Discussion |
| 11:20 | COFFEE BREAK / EXHIBITION AND NETWORKING |
| TBC |
| Chairs: Angelique Smit, Lead Clinical and Research NAC Nurse, National Amyloidosis Centre, Royal Free London NHS Foundation Trust, London; and Dr David Mulcahy, Consultant Cardiologist, Blackrock Health Hermitage Clinic, Dublin | |
| 12:25 | Lipoprotein(a) and atherosclerotic disease – causal or innocent bystander? Dr Andreas Tridimas, Consultant in Chemical Pathology and Metabolic Medicine, Clinical Biochemistry Department, Countess of Chester Hospital and Wirral University Teaching Hospital |
| 12:45 | Anaemia, breathlessness, cardiomegaly…and the multimorbid amyloid patient Dr Sarah Birkhoelzer, Heart Failure and Imaging Fellow, University Hospitals Dorset |
| 13.05 | Discussion |
| 13:10 | LUNCH BREAK / EXHIBITION AND NETWORKING |
| TBC. |
| Chairs: Carys Barton, Heart Failure Nurse Consultant, Imperial NHS Foundation Trust, London; Chair, British Society for Heart Failure; and Dr Kathrine Parker, Highly Specialist Renal Pharmacist, Manchester University NHS Foundation Trust; UKKA Academic Vice President | |
| 14:50 | AKI, RAASi and nephroprotection Dr Jonathan Murray, Consultant Nephrologist, South Tees NHS Foundation Trust |
| 15:05 | It's just a bit of HF or mild HF Dr Lisa Anderson, Heart Failure Consultant, St George’s University Hospital NHS Foundation Trust |
| 15.20 | Discussion |
| 15:25 | TEA BREAK / EXHIBITION AND NETWORKING |
| Chair: TBC | |
| 15:50 | Cardiac trials Dr Geraint Morton, Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
| 16:05 | Renal trials Dr David Lappin, Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway |
| 16.20 | Discussion |
| Chair: TBC | |
| 16:25 | Pulmonary arterial hypertension TBC |
| 16:40 | Resistant angina – coronary sinus reducer as a novel option Dr Kevin Cheng, BHF Research Fellow, Specialty Registrar in Cardiology, Imperial College London |
| 16.55 | Discussion |
| 17:00 | Meeting close |